Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles
Sánchez-Juan et al. reveal an association between serum GFAP levels and post-mortem tau pathology in patients with dementia, independent of amyloid deposit